Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 132
Filter
1.
Front Endocrinol (Lausanne) ; 14: 1160884, 2023.
Article in English | MEDLINE | ID: mdl-37214245

ABSTRACT

Diagnosis and management of individuals who have differences of sex development (DSD) due to numerical or structural variations of sex chromosomes (NSVSC) remains challenging. Girls who have Turner syndrome (45X) may present with varying phenotypic features, from classical/severe to minor, and some remain undiagnosed. Boys and girls who have 45,X/46,XY chromosomal mosaicism may have Turner syndrome-like features and short stature; therefore, unexplained short stature during childhood requires karyotype analysis in both sexes, particularly if characteristic features or atypical genitalia are present. Many individuals with Klinefelter syndrome (47XXY) remain undiagnosed or are only diagnosed as adults due to fertility problems. Newborn screening by heel prick tests could potentially identify sex chromosome variations but would have ethical and financial implications, and in-depth cost-benefit analyses are needed before nationwide screening can be introduced. Most individuals who have NSVSC have lifelong co-morbidities and healthcare should be holistic, personalized and centralized, with a focus on information, psychosocial support and shared decision-making. Fertility potential should be assessed individually and discussed at an appropriate age. Oocyte or ovarian tissue cryopreservation is possible in some women who have Turner syndrome and live births have been reported following assisted reproductive technology (ART). Testicular sperm cell extraction (TESE) is possible in some men who have 45,X/46,XY mosaicism, but there is no established protocol and no reported fathering of children. Some men with Klinefelter syndrome can now father a child following TESE and ART, with multiple reports of healthy live births. Children who have NSVSC, their parents and DSD team members need to address possibilities and ethical questions relating to potential fertility preservation, with guidelines and international studies still needed.


Subject(s)
Klinefelter Syndrome , Turner Syndrome , Male , Female , Humans , Turner Syndrome/diagnosis , Turner Syndrome/genetics , Turner Syndrome/therapy , Klinefelter Syndrome/diagnosis , Klinefelter Syndrome/genetics , Klinefelter Syndrome/therapy , Semen , Mosaicism , Sex Chromosomes
2.
Eur Urol Focus ; 9(1): 6-7, 2023 01.
Article in English | MEDLINE | ID: mdl-36220761

ABSTRACT

In adolescents with Klinefelter syndrome (KS), cryopreservation would require surgery, which might delay testosterone therapy needed for testosterone deficiency. As surgical sperm retrieval rates are similar for all age groups in the KS population, fertility preservation in KS adolescents should not be recommended.


Subject(s)
Fertility Preservation , Klinefelter Syndrome , Humans , Male , Adolescent , Klinefelter Syndrome/complications , Klinefelter Syndrome/therapy , Semen , Sperm Retrieval , Testosterone/therapeutic use
3.
Front Endocrinol (Lausanne) ; 13: 909830, 2022.
Article in English | MEDLINE | ID: mdl-35813640

ABSTRACT

Klinefelter syndrome (KS) is the most common aneuploidy in men and has long-term sequelae on health and wellbeing. KS is a chronic, lifelong condition and adolescents/young adults (AYAs) with KS face challenges in transitioning from pediatric to adult-oriented services. Discontinuity of care contributes to poor outcomes for health and wellbeing and transition programs for KS are lacking. We aimed to develop and test a mobile health tool (KS Transition Passport) to educate patients about KS, encourage self-management and support successful transition to adult-oriented care. First, we conducted a retrospective chart review and patient survey to examine KS transition at a university hospital. Second, we conducted a systematic scoping review of the literature on AYAs with KS. Last, we developed a mobile health transition passport and evaluated it with patient support groups. Participants evaluated the tool using the System Usability Scale and Patient Education Materials Assessment Tool (PEMAT). Chart review identified 21 AYAs diagnosed between 3.9-16.8 years-old (median 10.2 years). The survey revealed only 4/10 (40%) were on testosterone therapy and fewer (3/10, 30%) had regular medical care. The scoping review identified 21 relevant articles highlighting key aspects of care for AYAs with KS. An interprofessional team developed the mobile-health KS transition passport using an iterative process. Support group members (n=35) rated passport usability as 'ok' to 'good' (70 ± 20, median 73.5/100). Of PEMAT dimensions, 5/6 were deemed 'high quality' (86-90/100) and participants knew what to do with the information (actionability = 83/100). In conclusion, many patients with KS appear to have gaps in transition to adult-oriented care. Iterative development of a KS transition passport produced a mobile health tool that was usable, understandable and had high ratings for actionability.


Subject(s)
Klinefelter Syndrome , Telemedicine , Adolescent , Child , Child, Preschool , Chronic Disease , Health Transition , Humans , Klinefelter Syndrome/diagnosis , Klinefelter Syndrome/therapy , Male , Puberty , Retrospective Studies , Young Adult
4.
Nutrients ; 14(10)2022 May 18.
Article in English | MEDLINE | ID: mdl-35631248

ABSTRACT

Klinefelter syndrome is the most common sex chromosomal aneuploidy in males. It is well known that patients with this syndrome have greater mortality and morbidity compared to the general population due to cardiovascular diseases and endocrine metabolism disorders. This augmented risk is due both to hypogonadism and to the syndrome itself. Therefore, correct hormonal replacement therapy and early primary prevention are crucial to these patients. Even though different studies are available on this topic in adult patients, only a few authors have focused on the paediatric population. Thus, in this narrative review, we report the current knowledge of metabolic and nutritional aspects in children with Klinefelter syndrome.


Subject(s)
Cardiovascular Diseases , Hypogonadism , Klinefelter Syndrome , Adult , Cardiovascular Diseases/etiology , Child , Endocrine System , Hormone Replacement Therapy , Humans , Hypogonadism/drug therapy , Klinefelter Syndrome/complications , Klinefelter Syndrome/epidemiology , Klinefelter Syndrome/therapy , Male
5.
Ann Endocrinol (Paris) ; 83(3): 172-176, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35526602

ABSTRACT

Patients with a Klinefelter syndrome (KS), defined by a 47 XXY karyotype, were long considered infertile. Testicular sperm extraction (TESE) now allows them to access fatherhood. We will present the data of studies since first experiment of TESE. Several factors influencing TESE outcome were proposed in these different studies. Among them, clinical and hormonal parameters have reported by few studies, age has been one of the most discussed prognostic factor of positive sperm retrieval rate. Data seems to show that TESE carried out before an age greater than 30 has a poorer prognosis for positive sperm retrieval. In few studies performed in younger patient, before 20 years, SRR was closed to result for 20 to 30 year old patients. Offering a TESE before 16 years old does not improve positive sperm extraction rate. In fact, the few studies carried out before the age of 16 were of poorer prognosis, most often linked to insufficient maturation of the residual gametes. In addition, androgen therapy, frequently prescribed in case of Klinefelter syndrome, did not seem to show any effect on sperm retrieval but only few studies were interested in the possible impact of this treatment. In conclusion, further studies are necessary to determine the interest of new markers to predict the chance of sperm retrieval, taking into account age, hormonal therapy.


Subject(s)
Azoospermia , Klinefelter Syndrome , Adolescent , Adult , Fertility , Humans , Klinefelter Syndrome/complications , Klinefelter Syndrome/therapy , Male , Retrospective Studies , Sperm Retrieval , Spermatozoa , Testis , Young Adult
8.
JBRA Assist Reprod ; 26(3): 412-421, 2022 08 04.
Article in English | MEDLINE | ID: mdl-34751018

ABSTRACT

OBJECTIVE: The current study aimed to present the clinical outcomes of 76 azoospermic patients with non-mosaic Klinefelter syndrome (KS), treated with testicular spermatozoa extraction (TESE) followed by intracytoplasmic sperm injection (ICSI) using either fresh or cryopreserved testicular spermatozoa. METHODS: We retrospectively evaluated 76 patients with non-mosaic KS belonging to a special group of cases that besides infertility did not present the classical signs and symptoms of testosterone deficiency. One of the patients repeated the TESE procedure (76 patients, 77 TESE cycles). Sixty of these 76 patients accepted to undergo TESE associated with ovarian stimulation, while 16 patients underwent TESE followed by testicular spermatozoa cryopreservation. Aneuploidy screening of the offspring was performed by Multiplex ligation-dependent probe amplification and by amniotic fluid karyotyping. Statistical analysis used the Chi-Squared Test, Fisher's Exact Test, 2-sided, for rates, and the Independent Samples T-test for equality of means, 2-sided. RESULTS: Testicular spermatozoa were recovered in 31 (40.3%) of the attempts. The patients underwent 47 ICSI cycles, 25 with fresh testicular spermatozoa and 22 with cryopreserved testicular spermatozoa. Fertilization (63.5% vs. 41.6%, p=0.000), implantation (37% vs. 13.2%, p=0.014), clinical pregnancy (60.9% vs. 19%, p=0.005) and live birth (65.2% vs. 23.8%, p=0.006) rates were higher with fresh testicular spermatozoa. Chromosome analysis of the 21 newborns was normal. CONCLUSIONS: The present data adds further information regarding the recovery rate of spermatozoa after TESE and the embryological and clinical outcomes with fresh and cryopreserved testicular spermatozoa, besides reassuring the safety concerning chromosomal transmission of KS from parents to their offspring.


Subject(s)
Klinefelter Syndrome , Female , Humans , Infant, Newborn , Klinefelter Syndrome/genetics , Klinefelter Syndrome/therapy , Male , Pregnancy , Retrospective Studies , Semen , Sperm Retrieval , Spermatozoa/physiology
10.
Asian J Androl ; 23(6): 621-626, 2021.
Article in English | MEDLINE | ID: mdl-33904506

ABSTRACT

This retrospective study demonstrates the clinical outcomes of patients with nonmosaic Klinefelter's syndrome (KS) who underwent preimplantation genetic testing (PGT) with frozen-thawed testicular spermatozoa. Microdissection testicular sperm extraction (micro-TESE) was performed for sperm retrieval. Next-generation sequencing (NGS) was conducted for embryo analysis. A total of 18 couples aged ≤35 years were included, and 22 oocyte retrieval cycles were completed. Euploidy was detected in 29 of 45 (64.4%) embryos. Additionally, the numbers of aneuploid and mosaic embryos detected were 8 (17.8%) and 8 (17.8%), respectively, regardless of a lack of sex chromosome abnormalities. Finally, 13 couples with euploid embryos completed 14 frozen embryo transfer (FET) cycles. Ten couples had clinical pregnancies, and 6 of them had already delivered 5 healthy babies and 1 monozygotic twin. There were also 4 ongoing pregnancies and 2 biochemical pregnancies, but no early pregnancy loss was reported. Based on our results, we speculate that for KS patients, when sperm can be obtained by micro-TESE, the cryopreservation strategy makes the ovarian stimulation procedure more favorable for female partners. The paternal genetic risk of sex chromosome abnormalities in their offspring is extremely low in men with KS. In addition to PGT, the intracytoplasmic sperm injection (ICSI) procedure is comparably effective but more economical for young nonmosaic KS couples. ICSI should be offered as an option for such couples, but monitoring by prenatal genetic diagnosis is recommended.


Subject(s)
Klinefelter Syndrome/therapy , Outcome Assessment, Health Care/statistics & numerical data , Ovulation Induction/methods , Adult , Female , High-Throughput Nucleotide Sequencing/methods , Humans , Klinefelter Syndrome/genetics , Outcome Assessment, Health Care/methods , Ovulation Induction/statistics & numerical data , Pregnancy , Retrospective Studies , Sperm Injections, Intracytoplasmic/methods
11.
Am J Intellect Dev Disabil ; 126(1): 1-13, 2021 01 01.
Article in English | MEDLINE | ID: mdl-33370785

ABSTRACT

Klinefelter syndrome (47,XXY) is associated with problems in social interaction and behavioral adaptation. Sixteen adolescents and adult men with 47,XXY enrolled in a pilot-study evaluating the effectiveness of Social Management Training (SMT), a novel neurocognitive-behavioral treatment program targeted at improving social, emotional, and behavioral functioning. Participants reported improved emotional stability from pre- to post-test (5 months). Informants reported reductions in internalizing and externalizing symptoms, including improvement in self-regulation. Although informants did not report changes in autism-like symptoms, increased awareness of social challenges was found. SMT may improve emotional stability, self-regulation, and self-reflection in people males with Klinefelter syndrome. This potentially efficacious treatment approach may prove to be a promising psychosocial therapeutic intervention for this population.


Subject(s)
Autistic Disorder , Klinefelter Syndrome , Problem Behavior , Adolescent , Adult , Emotions , Humans , Klinefelter Syndrome/therapy , Male , Pilot Projects
12.
J Endocrinol Invest ; 44(5): 1053-1063, 2021 May.
Article in English | MEDLINE | ID: mdl-32865776

ABSTRACT

PURPOSE: We aimed to verify if 1 year-testosterone-replacement therapy could produce a psychopathological recovery and a satisfactory quality of life in Klinefelter syndrome (KS) patients compared to matched healthy controls. Further, we analyzed personality traits and coping strategies, an issue not yet examined in androgen-treated KS patients. We also enquired whether any of the sociodemographic and psychological variables might predict a patient's general and sexual life satisfaction. METHODS: The Quality of Life Enjoyment and Satisfaction Questionnaire and the Temperament and Character Inventory-Revised were administered to both 23 KS patients and matched healthy subjects. Psychopathology was investigated by the Symptom Checklist-90-Revised (SCL-90-R) and the Mini-mental State Examination. The COPE Inventory was used to identify cognitive and behavioral strategies to manage disease-related distress. RESULTS: In testosterone-treated KS patients, when compared with controls, SCL-90-R subscales analysis evidenced high psychological distress, mainly presented as obsessive thoughts, hanger-hostility, phobias, and psychoticism. Self-directedness and self-transcendence, along with the prevalent use of emotion-focused coping strategies, outlined the personality of our KS patients. Depression and somatization proved to be predictors of general life dissatisfaction. Depression, anger-hostility, and paranoid ideation, instead, emerged as predictors of sexual life dissatisfaction. CONCLUSION: Endocrinologists should cooperate with mental health providers to foster a better outcome of the disease in KS patients.


Subject(s)
Adaptation, Psychological/physiology , Cognition , Hormone Replacement Therapy , Klinefelter Syndrome , Quality of Life , Testosterone/therapeutic use , Adult , Hormone Replacement Therapy/methods , Hormone Replacement Therapy/psychology , Humans , Italy/epidemiology , Klinefelter Syndrome/epidemiology , Klinefelter Syndrome/psychology , Klinefelter Syndrome/therapy , Male , Mental Health , Mental Status and Dementia Tests , Personality Assessment , Psychological Distress , Sexual Behavior
13.
Asian Journal of Andrology ; (6): 621-626, 2021.
Article in English | WPRIM (Western Pacific) | ID: wpr-922367

ABSTRACT

This retrospective study demonstrates the clinical outcomes of patients with nonmosaic Klinefelter's syndrome (KS) who underwent preimplantation genetic testing (PGT) with frozen-thawed testicular spermatozoa. Microdissection testicular sperm extraction (micro-TESE) was performed for sperm retrieval. Next-generation sequencing (NGS) was conducted for embryo analysis. A total of 18 couples aged ≤35 years were included, and 22 oocyte retrieval cycles were completed. Euploidy was detected in 29 of 45 (64.4%) embryos. Additionally, the numbers of aneuploid and mosaic embryos detected were 8 (17.8%) and 8 (17.8%), respectively, regardless of a lack of sex chromosome abnormalities. Finally, 13 couples with euploid embryos completed 14 frozen embryo transfer (FET) cycles. Ten couples had clinical pregnancies, and 6 of them had already delivered 5 healthy babies and 1 monozygotic twin. There were also 4 ongoing pregnancies and 2 biochemical pregnancies, but no early pregnancy loss was reported. Based on our results, we speculate that for KS patients, when sperm can be obtained by micro-TESE, the cryopreservation strategy makes the ovarian stimulation procedure more favorable for female partners. The paternal genetic risk of sex chromosome abnormalities in their offspring is extremely low in men with KS. In addition to PGT, the intracytoplasmic sperm injection (ICSI) procedure is comparably effective but more economical for young nonmosaic KS couples. ICSI should be offered as an option for such couples, but monitoring by prenatal genetic diagnosis is recommended.


Subject(s)
Adult , Female , Humans , Pregnancy , High-Throughput Nucleotide Sequencing/methods , Klinefelter Syndrome/therapy , Outcome Assessment, Health Care/statistics & numerical data , Ovulation Induction/statistics & numerical data , Retrospective Studies , Sperm Injections, Intracytoplasmic/methods
14.
Best Pract Res Clin Endocrinol Metab ; 34(6): 101480, 2020 12.
Article in English | MEDLINE | ID: mdl-33358481

ABSTRACT

Klinefelter syndrome (KS) is defined as the presence of one or more extra "X" chromosome in a male patient. It affects approximately 1 in 600 newborn males and the most common chromosomal abnormality, leading to male hypogonadism and infertility. There is a lack of data supporting best practices for KS patients' care. In this paper we review controversial issues in KS research ranging from mechanisms of variation in KS phenotype to abnormalities resulting in reduced sperm production to successful sperm retrieval disparities after testicular sperm extraction (TESE). Translation to live birth and offspring health is also examined. Finally, medical therapies used to optimize the hormonal status and chances of fertility in KS patients are reviewed. We will also discuss the experimental spermatogonial stem cell (SSC) treatments, which are considered the future for TESE negative patients.


Subject(s)
Infertility, Male/etiology , Infertility, Male/therapy , Klinefelter Syndrome/complications , Klinefelter Syndrome/therapy , Humans , Infant, Newborn , Infertility, Male/diagnosis , Infertility, Male/genetics , Klinefelter Syndrome/diagnosis , Klinefelter Syndrome/genetics , Male , Neonatal Screening , Sperm Retrieval , Spermatozoa/abnormalities , Spermatozoa/metabolism , Testis/metabolism , Testis/pathology
15.
Fertil Steril ; 114(5): 997-1005, 2020 11.
Article in English | MEDLINE | ID: mdl-32868102

ABSTRACT

OBJECTIVE: To investigate whether preoperative human chorionic gonadotropin (hCG) treatment can help predict the outcomes of microdissection testicular sperm extraction (micro-TESE) and affect fertility outcomes in non-mosaic Klinefelter syndrome (KS) patients. DESIGN: Retrospective cohort study. SETTING: University-affiliated fertility center. PATIENT(S): A total of 184 non-mosaic KS patients who underwent micro-TESE with or without preoperative hCG treatment from January 2016 to July 2019. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Sperm retrieval rate (SRR) with and without hCG treatment, logistic models analysis. RESULT(S): Eighty KS patients (43.5%) had successful sperm retrievals after micro-TESE. There was no statistically significant difference in the SRR between the group who received hCG treatment and the group that did not (44.0% vs. 43.3%). Logistic regression analyses demonstrated that the hCG treatment had no statistically significant effect on successful sperm retrieval. However, higher preoperative testosterone (T) levels seemed to be associated with a higher probability of successful sperm retrieval (multivariate adjusted odds ratio 1.09; 95% confidence interval [CI], 1.04-1.16). The prediction model for SRR on KS patients had an area under the curve of 67.3% (95% CI, 59.3-75.3%). In the hCG treatment group, the data indicated that the three parameters of testicular volume, pretreatment T level, and alterations of T were associated with the probability of successful sperm retrieval. Moreover, hCG therapy did not affect intracytoplasmic sperm injection (ICSI) outcomes. No differences in the pregnancy rate or live-birth rate were observed between the two groups. CONCLUSION(S): Therapy with hCG does not affect SRR or ICSI outcomes of non-mosaic KS patients. However, preoperative T levels, whether treated with hCG or not, can predict the chance of sperm retrieval with micro-TESE.


Subject(s)
Chorionic Gonadotropin/administration & dosage , Klinefelter Syndrome/therapy , Microdissection/methods , Sperm Injections, Intracytoplasmic/methods , Sperm Retrieval , Testis/surgery , Adult , Chorionic Gonadotropin/blood , Cohort Studies , Female , Humans , Klinefelter Syndrome/blood , Male , Ovulation Induction/methods , Retrospective Studies , Testis/cytology , Treatment Outcome
17.
J Assist Reprod Genet ; 37(9): 2053-2079, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32562095

ABSTRACT

PURPOSE: Patients with Klinefelter syndrome (KS) who receive assisted reproductive technology (ART) treatment often experience poor pregnancy rates due to decreased fertilization, cleavage, and implantation rates and even an increased miscarriage rate. Mounting evidence from recent studies has shown that various technological advances and approaches could facilitate the success of ART treatment for KS patients. In this review, we summarize the methods for guiding KS patients during ART and for developing optimal strategies for preserving fertility, improving pregnancy rate and live birth rate, and avoiding the birth of KS infants. METHODS: We searched PubMed and Google Scholar publications related to KS patients on topics of controlled ovarian stimulation protocols, sperm extraction, fertility preservation, gamete artificial activation, round spermatid injection (ROSI), and non-invasive prenatal screening (PGD) methods. RESULTS: This review outlines the different ovulation-inducing treatments for female partners according to the individual sperm status in the KS patient. We further summarize the methods of retrieving sperm, storing, and freezing rare sperm. We reviewed different methods of gamete artificial activation and discussed the feasibility of ROSI for sterile KS patients who absolutely lack sperm. The activation of eggs in the process of intracytoplasmic sperm injection and non-invasive PGD are urgently needed to prevent the birth of KS infants. CONCLUSION: The integrated strategies will pave the way for the establishment of ART treatment approaches and improve the clinical outcome for KS patients.


Subject(s)
Embryo Implantation/genetics , Klinefelter Syndrome/therapy , Reproductive Techniques, Assisted/trends , Birth Rate , Female , Fertility Preservation/trends , Humans , Klinefelter Syndrome/genetics , Klinefelter Syndrome/pathology , Male , Pregnancy , Pregnancy Rate , Sperm Injections, Intracytoplasmic/trends
18.
Curr Opin Obstet Gynecol ; 32(2): 140-146, 2020 04.
Article in English | MEDLINE | ID: mdl-32004174

ABSTRACT

PURPOSE OF REVIEW: Although 47,XXY (Klinefelter syndrome) was first discovered more than 50 years ago, there have been limited comprehensive studies on this disorder. The present review explains the study of neurodevelopmental dysfunction and the impact of testosterone replacement at specific junctions in the life of males with 47,XXY. The intricate relationship between testosterone, neurodevelopment, health, and well being warrants an in-depth investigation in order to achieve optimal outcomes. RECENT FINDINGS: Current literature suggests that the implementation of biological treatment has a positive impact on numerous areas of neurodevelopment. Further research is needed to determine ideal dosage, timing, and frequency of biological treatment for efficacy and safety of the child with 47,XXY. SUMMARY: As noninvasive prenatal screening has detected increasing numbers of fetuses with 47,XXY, parents may benefit from both prenatal and postnatal counseling, including the latest innovative biological treatment, that may further optimize the child's outcome, especially when coupled with targeted early intervention services.


Subject(s)
Child Development/drug effects , Klinefelter Syndrome/therapy , Testosterone/administration & dosage , Adolescent , Child , Child, Preschool , Hormone Replacement Therapy/methods , Humans , Infant , Male , Testosterone/adverse effects , Testosterone/pharmacology
19.
Best Pract Res Clin Endocrinol Metab ; 34(6): 101475, 2020 12.
Article in English | MEDLINE | ID: mdl-33419659

ABSTRACT

The understanding of male factors of infertility has grown exponentially in the past ten years. While clear guidelines for obstructive azoospermia have been developed, management of non-obstructive azoospermia has lagged. Specifically, management of Kallmann Syndrome and central non-obstructive azoospermia has been limited by a lack of understanding of the molecular pathogenesis and investigational trials exploring the best option for management and fertility in these patients. This review aims to summarize our current understanding of the causes of central hypogonadotropic hypogonadism with a focus on genetic etiologies while also discussing options that endocrinologists and urologists can utilize to successfully treat this group of infertile men.


Subject(s)
Azoospermia , Kallmann Syndrome , Azoospermia/epidemiology , Azoospermia/etiology , Azoospermia/genetics , Azoospermia/therapy , Humans , Hypogonadism/complications , Hypogonadism/epidemiology , Hypogonadism/genetics , Hypogonadism/therapy , Infertility, Male/complications , Infertility, Male/epidemiology , Infertility, Male/genetics , Infertility, Male/therapy , Kallmann Syndrome/complications , Kallmann Syndrome/epidemiology , Kallmann Syndrome/genetics , Kallmann Syndrome/therapy , Klinefelter Syndrome/complications , Klinefelter Syndrome/epidemiology , Klinefelter Syndrome/genetics , Klinefelter Syndrome/therapy , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...